Episode

Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026

Podcast: Decera Clinical Education Oncology Podcast
Published: Mar 23, 2026
Duration seconds: 1137
Processing state: not_requested
Canonical source: https://oncologypodcast.simplecast.com/episodes/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026-VT2A9cW5
Audio: https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/56d305ca-5864-4447-8c5d-f52144e4f71f/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=56d305ca-5864-4447-8c5d-f52144e4f71f&feed=GlfUTtJq
JSON: /v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026
Markdown: /podcast/decera-clinical-education-oncology-podcast-1302999/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026.md

Actions

POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, experts discuss the rapidly evolving bladder cancer treatment landscape, including new options for BCG-unresponsive disease, emerging perioperative regimens, and the growing role of biomarkers and multidisciplinary care in guiding treatment decisions.